01.10.2011 • News • Momenta Pharmaceuticals • Watson Pharmaceuticals

Momenta Files for Injunction Against Amphastar, Watson and Int'l Medical Systems

 

Momenta Pharmaceuticals announced that it has filed a request for a temporary restraining order and preliminary injunction to prevent Amphastar Pharmaceuticals, Watson Pharmaceuticals and International Medical Systems from launching their enoxaparin sodium product in the United States.

On September 21, 2011 Momenta announced that it had sued Amphastar, Watson, and International Medical Systems in the United States District Court for the District of Massachusetts for infringement of two Momenta patents.

The patents cover the company's methods of producing enoxaparin sodium.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Top-Feature

most read

Photo
28.07.2025 • News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.